Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis

NCT03001323 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped Enrollment was too low to provide statistically significant data

Conditions

Diabetes Mellitus

Interventions

DRUG: Degludec
DRUG: Standard long-acting

Sponsor

Hennepin Healthcare Research Institute